Recurrence curves showed that the patients with CRC with high PCID2 expression had increased risk of recurrence compared with those with low PCID2 (P < 0.05 for Cohort I and P < 0.01 for Cohort II, log-rank test) (Fig. 1F). Here, PCID2 is linked to colorectal carcinoma.